Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently characterized form of dementia that is distinct ...

January is Alzheimer's Awareness Month in Canada. According to the Alzheimer's Association, almost 750,000 Canadians are ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Fact checked by Nick Blackmer By 2060, nearly 14 million Americans may be living with Alzheimer’s disease. We still don’t ...

NHS outlines early signs of dementia which will affect one in two of us during our lifetimes - either by developing the ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

"This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer ...

Brain damage caused by dementia can lead to anxiety, fear, and irritability, especially in the evening. This is how ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...